BioLife Solutions, Inc. (BLFS)
USD 21.86
(4.14%)
USD 21.86
(4.14%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -66.42 Million USD | 52.49% |
| 2022 | -139.8 Million USD | -1567.72% |
| 2021 | -8.38 Million USD | -414.32% |
| 2020 | 2.66 Million USD | -75.89% |
| 2019 | 11.06 Million USD | 238.7% |
| 2018 | 3.26 Million USD | 229.86% |
| 2017 | -2.51 Million USD | 63.42% |
| 2016 | -6.87 Million USD | -63.15% |
| 2015 | -4.21 Million USD | -30.96% |
| 2014 | -3.21 Million USD | -196.8% |
| 2013 | -1.08 Million USD | 34.67% |
| 2012 | -1.65 Million USD | 15.18% |
| 2011 | -1.95 Million USD | 1.36% |
| 2010 | -1.98 Million USD | 28.35% |
| 2009 | -2.76 Million USD | 0.24% |
| 2008 | -2.77 Million USD | 2.69% |
| 2007 | -2.85 Million USD | -151.48% |
| 2006 | -1.13 Million USD | -83.11% |
| 2005 | -619.32 Thousand USD | 16.66% |
| 2004 | -743.16 Thousand USD | 42.98% |
| 2003 | -1.3 Million USD | -703.76% |
| 2002 | 215.87 Thousand USD | 104.89% |
| 2001 | -4.41 Million USD | -59.1% |
| 2000 | -2.77 Million USD | -135.76% |
| 1999 | -1.17 Million USD | 7.3% |
| 1998 | -1.26 Million USD | 20.23% |
| 1997 | -1.58 Million USD | 0.0% |
| 1996 | - USD | 100.0% |
| 1995 | -2.23 Million USD | 14.2% |
| 1994 | -2.6 Million USD | 60.61% |
| 1993 | -6.6 Million USD | -40.43% |
| 1992 | -4.7 Million USD | -80.77% |
| 1991 | -2.6 Million USD | -52.94% |
| 1990 | -1.7 Million USD | -240.0% |
| 1989 | -500 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -10.22 Million USD | 23.63% |
| 2024 Q2 | -11.82 Million USD | -102.71% |
| 2023 Q1 | -13.71 Million USD | 72.12% |
| 2023 FY | -66.42 Million USD | 52.49% |
| 2023 Q2 | -10.19 Million USD | 25.63% |
| 2023 Q4 | -13.38 Million USD | 54.06% |
| 2023 Q3 | -29.13 Million USD | -185.64% |
| 2022 FY | -139.8 Million USD | -1567.72% |
| 2022 Q1 | -7.06 Million USD | 53.57% |
| 2022 Q2 | -72.55 Million USD | -926.8% |
| 2022 Q3 | -9.95 Million USD | 86.28% |
| 2022 Q4 | -49.19 Million USD | -394.02% |
| 2021 FY | -8.38 Million USD | -414.32% |
| 2021 Q3 | 79 Thousand USD | -99.0% |
| 2021 Q2 | 7.87 Million USD | 804.47% |
| 2021 Q4 | -15.22 Million USD | -19365.82% |
| 2021 Q1 | -1.11 Million USD | 47.49% |
| 2020 Q1 | 22.3 Million USD | 4537.84% |
| 2020 Q3 | -1.13 Million USD | 93.08% |
| 2020 Q4 | -2.12 Million USD | -87.91% |
| 2020 FY | 2.66 Million USD | -75.89% |
| 2020 Q2 | -16.38 Million USD | -173.43% |
| 2019 Q4 | 481 Thousand USD | -94.84% |
| 2019 Q1 | 427 Thousand USD | -52.18% |
| 2019 Q2 | 838 Thousand USD | 96.25% |
| 2019 FY | 11.06 Million USD | 238.7% |
| 2019 Q3 | 9.31 Million USD | 1011.69% |
| 2018 Q1 | 3482.00 USD | 100.62% |
| 2018 FY | 3.26 Million USD | 229.86% |
| 2018 Q4 | 893 Thousand USD | -27.44% |
| 2018 Q3 | 1.23 Million USD | 8.04% |
| 2018 Q2 | 1.13 Million USD | 32616.2% |
| 2017 Q1 | -870.29 Thousand USD | 73.82% |
| 2017 Q2 | -768.21 Thousand USD | 11.73% |
| 2017 FY | -2.51 Million USD | 63.42% |
| 2017 Q4 | -558 Thousand USD | -75.08% |
| 2017 Q3 | -318.71 Thousand USD | 58.51% |
| 2016 Q3 | -969 Thousand USD | 28.54% |
| 2016 Q2 | -1.35 Million USD | -10.54% |
| 2016 Q1 | -1.22 Million USD | -9.6% |
| 2016 FY | -6.87 Million USD | -63.15% |
| 2016 Q4 | -3.32 Million USD | -243.03% |
| 2015 Q3 | -1.06 Million USD | -7.47% |
| 2015 Q2 | -994.37 Thousand USD | 3.6% |
| 2015 Q4 | -1.11 Million USD | -4.74% |
| 2015 FY | -4.21 Million USD | -30.96% |
| 2015 Q1 | -1.03 Million USD | -13.03% |
| 2014 FY | -3.21 Million USD | -196.8% |
| 2014 Q4 | -912.56 Thousand USD | -5.81% |
| 2014 Q3 | -862.45 Thousand USD | 2.37% |
| 2014 Q2 | -883.35 Thousand USD | -57.92% |
| 2014 Q1 | -559.37 Thousand USD | -15.44% |
| 2013 Q2 | -282.5 Thousand USD | -3836.82% |
| 2013 Q3 | -309.91 Thousand USD | -9.7% |
| 2013 Q4 | -484.56 Thousand USD | -56.36% |
| 2013 FY | -1.08 Million USD | 34.67% |
| 2013 Q1 | -7176.00 USD | 98.6% |
| 2012 Q4 | -511.58 Thousand USD | -45.24% |
| 2012 Q3 | -352.22 Thousand USD | 29.4% |
| 2012 Q1 | -296.87 Thousand USD | 27.8% |
| 2012 Q2 | -498.89 Thousand USD | -68.05% |
| 2012 FY | -1.65 Million USD | 15.18% |
| 2011 Q4 | -411.17 Thousand USD | 14.1% |
| 2011 Q2 | -436.67 Thousand USD | 30.7% |
| 2011 Q1 | -630.12 Thousand USD | -33.89% |
| 2011 Q3 | -478.66 Thousand USD | -9.62% |
| 2011 FY | -1.95 Million USD | 1.36% |
| 2010 FY | -1.98 Million USD | 28.35% |
| 2010 Q4 | -470.63 Thousand USD | -7.76% |
| 2010 Q3 | -436.73 Thousand USD | 18.69% |
| 2010 Q2 | -537.14 Thousand USD | -1.01% |
| 2010 Q1 | -531.77 Thousand USD | -49.7% |
| 2009 Q1 | -839.56 Thousand USD | -4.39% |
| 2009 Q3 | -562.62 Thousand USD | 44.46% |
| 2009 Q2 | -1.01 Million USD | -20.65% |
| 2009 Q4 | -355.23 Thousand USD | 36.86% |
| 2009 FY | -2.76 Million USD | 0.24% |
| 2008 FY | -2.77 Million USD | 2.69% |
| 2008 Q2 | -662.49 Thousand USD | -2.63% |
| 2008 Q4 | -804.27 Thousand USD | -21.34% |
| 2008 Q1 | -645.52 Thousand USD | 13.46% |
| 2008 Q3 | -662.82 Thousand USD | -0.05% |
| 2007 Q3 | -761.59 Thousand USD | -1.18% |
| 2007 Q1 | -591.53 Thousand USD | -1509.74% |
| 2007 Q2 | -752.72 Thousand USD | -27.25% |
| 2007 Q4 | -745.91 Thousand USD | 2.06% |
| 2007 FY | -2.85 Million USD | -151.48% |
| 2006 Q3 | -396.92 Thousand USD | 18.88% |
| 2006 Q4 | -36.74 Thousand USD | 90.74% |
| 2006 FY | -1.13 Million USD | -83.11% |
| 2006 Q1 | -211.01 Thousand USD | -23.53% |
| 2006 Q2 | -489.32 Thousand USD | -131.89% |
| 2005 Q1 | -162.77 Thousand USD | -60.15% |
| 2005 Q2 | -187.48 Thousand USD | -15.18% |
| 2005 Q3 | -156.95 Thousand USD | 16.28% |
| 2005 Q4 | -170.82 Thousand USD | -8.84% |
| 2005 FY | -619.32 Thousand USD | 16.66% |
| 2004 Q2 | -233.49 Thousand USD | 9.44% |
| 2004 FY | -743.16 Thousand USD | 42.98% |
| 2004 Q4 | -101.64 Thousand USD | 32.32% |
| 2004 Q3 | -150.17 Thousand USD | 35.68% |
| 2004 Q1 | -257.84 Thousand USD | -338.85% |
| 2003 Q4 | 107.95 Thousand USD | 118.97% |
| 2003 FY | -1.3 Million USD | -703.76% |
| 2003 Q1 | -333.47 Thousand USD | -14.72% |
| 2003 Q2 | -494.47 Thousand USD | -48.28% |
| 2003 Q3 | -569.06 Thousand USD | -15.09% |
| 2002 FY | 215.87 Thousand USD | 104.89% |
| 2002 Q1 | -382.2 Thousand USD | 53.95% |
| 2002 Q3 | -303 Thousand USD | -114.46% |
| 2002 Q2 | 2.09 Million USD | 648.33% |
| 2002 Q4 | -290.68 Thousand USD | 4.07% |
| 2001 Q1 | -1.07 Million USD | 1.27% |
| 2001 FY | -4.41 Million USD | -59.1% |
| 2001 Q4 | -830.03 Thousand USD | 26.82% |
| 2001 Q3 | -1.13 Million USD | 17.24% |
| 2001 Q2 | -1.37 Million USD | -27.46% |
| 2000 Q1 | -154 Thousand USD | 73.45% |
| 2000 Q4 | -1.08 Million USD | -61.34% |
| 2000 Q3 | -675.06 Thousand USD | 20.93% |
| 2000 Q2 | -853.73 Thousand USD | -454.37% |
| 2000 FY | -2.77 Million USD | -135.76% |
| 1999 Q1 | -300 Thousand USD | 18.55% |
| 1999 Q3 | -180 Thousand USD | -125.0% |
| 1999 Q4 | -580 Thousand USD | -222.22% |
| 1999 FY | -1.17 Million USD | 7.3% |
| 1999 Q2 | -80 Thousand USD | 73.33% |
| 1998 Q4 | -368.34 Thousand USD | -268.34% |
| 1998 Q1 | -700 Thousand USD | -18.65% |
| 1998 Q2 | -100 Thousand USD | 85.71% |
| 1998 Q3 | -100 Thousand USD | 0.0% |
| 1998 FY | -1.26 Million USD | 20.23% |
| 1997 FY | -1.58 Million USD | 0.0% |
| 1997 Q1 | -100 Thousand USD | 0.0% |
| 1997 Q3 | -300 Thousand USD | 50.0% |
| 1997 Q4 | -589.99 Thousand USD | -96.66% |
| 1997 Q2 | -600 Thousand USD | -500.0% |
| 1996 Q3 | -300 Thousand USD | 85.03% |
| 1996 Q1 | -400 Thousand USD | 33.33% |
| 1996 Q2 | -2 Million USD | -401.06% |
| 1996 FY | - USD | 100.0% |
| 1995 Q3 | -400 Thousand USD | 51.85% |
| 1995 FY | -2.23 Million USD | 14.2% |
| 1995 Q1 | -600 Thousand USD | -100.0% |
| 1995 Q4 | -600 Thousand USD | -50.0% |
| 1995 Q2 | -830.72 Thousand USD | -38.45% |
| 1994 Q2 | -300 Thousand USD | 75.0% |
| 1994 Q3 | -500 Thousand USD | -66.67% |
| 1994 Q1 | -1.2 Million USD | -100.0% |
| 1994 FY | -2.6 Million USD | 60.61% |
| 1994 Q4 | -300 Thousand USD | 40.0% |
| 1993 FY | -6.6 Million USD | -40.43% |
| 1993 Q4 | -600 Thousand USD | -20.0% |
| 1993 Q3 | -500 Thousand USD | 70.59% |
| 1993 Q2 | -1.7 Million USD | -21.43% |
| 1993 Q1 | -1.4 Million USD | 22.22% |
| 1992 Q2 | -1.5 Million USD | -25.0% |
| 1992 FY | -4.7 Million USD | -80.77% |
| 1992 Q4 | -1.8 Million USD | -5.88% |
| 1992 Q3 | -1.7 Million USD | -13.33% |
| 1992 Q1 | -1.2 Million USD | 0.0% |
| 1991 Q4 | -1.2 Million USD | -71.43% |
| 1991 FY | -2.6 Million USD | -52.94% |
| 1991 Q2 | -600 Thousand USD | -20.0% |
| 1991 Q1 | -500 Thousand USD | 28.57% |
| 1991 Q3 | -700 Thousand USD | -16.67% |
| 1990 Q3 | -800 Thousand USD | 0.0% |
| 1990 Q4 | -700 Thousand USD | 12.5% |
| 1990 Q1 | -300 Thousand USD | 25.0% |
| 1990 FY | -1.7 Million USD | -240.0% |
| 1990 Q2 | -800 Thousand USD | -166.67% |
| 1989 Q1 | -100 Thousand USD | 0.0% |
| 1989 FY | -500 Thousand USD | 0.0% |
| 1989 Q4 | -400 Thousand USD | -100.0% |
| 1989 Q3 | -200 Thousand USD | 0.0% |
| 1989 Q2 | -200 Thousand USD | -100.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | -4.902% |
| AngioDynamics, Inc. | -184.34 Million USD | 63.967% |
| AtriCure, Inc. | -30.43 Million USD | -118.237% |
| Avinger, Inc. | -18.32 Million USD | -262.593% |
| Azenta, Inc. | -14.25 Million USD | -365.926% |
| The Cooper Companies, Inc. | 294.2 Million USD | 122.579% |
| Daxor Corporation | 280.64 Thousand USD | 23769.826% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | -337.077% |
| Femasys Inc. | -14.24 Million USD | -366.248% |
| GlucoTrack, Inc. | -7.09 Million USD | -835.987% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -1845.154% |
| Hologic, Inc. | 789.5 Million USD | 108.414% |
| ICU Medical, Inc. | -29.65 Million USD | -123.999% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 103.694% |
| KORU Medical Systems, Inc. | -13.74 Million USD | -383.42% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 320.651% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -896.889% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -896.889% |
| Masimo Corporation | 81.5 Million USD | 181.506% |
| Microbot Medical Inc. | -10.74 Million USD | -518.501% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 671.395% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 170.359% |
| Nephros, Inc. | -1.57 Million USD | -4117.587% |
| NovoCure Limited | -207.04 Million USD | 67.916% |
| NEXGEL, Inc. | -3.15 Million USD | -2004.118% |
| NEXGEL, Inc. | -3.15 Million USD | -2004.118% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 29.944% |
| OraSure Technologies, Inc. | 53.65 Million USD | 223.804% |
| Pro-Dex, Inc. | 2.12 Million USD | 3223.037% |
| Pulse Biosciences, Inc. | -42.21 Million USD | -57.373% |
| Predictive Oncology Inc. | -13.98 Million USD | -375.023% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -2150.712% |
| QuidelOrtho Corporation | -10.1 Million USD | -557.693% |
| Repligen Corporation | 41.57 Million USD | 259.769% |
| Sanara MedTech Inc. | -4.3 Million USD | -1443.666% |
| STAAR Surgical Company | 21.34 Million USD | 411.177% |
| Sharps Technology, Inc. | -9.84 Million USD | -574.959% |
| Utah Medical Products, Inc. | 16.63 Million USD | 499.321% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 49.677% |
| Jin Medical International Ltd. | 2.87 Million USD | 2407.911% |